Seattle Children’s Hospital Awarded Accreditations from Commission of Cancer and ABRET

First standalone children’s hospital in Western United States to receive ABRET EEG Laboratories Accreditation

Seattle Children’s Hospital today announced it has earned accreditations from the Commission of Cancer (CoC) for its cancer program, and from The American Board of Registration of Electroencephalographic and Evoked Potential Technologists (ABRET) for its neurodiagnostic EEG laboratory, where abnormalities related to electrical activity of the brain are diagnosed. Both accreditations were awarded to recognize Children’s compliance with industry standards and commitment to providing high-quality patient care.

Children’s is the first standalone children’s hospital in the Western United States to be awarded the ABRET Accreditation for EEG Laboratories. The Hospital is among three in Washington state to be honored with this recognition.

Commission of Cancer Accreditation

The three-year CoC Accreditation was awarded to Seattle Children’s based on compliance with 36 standards spanning key areas such as early cancer diagnosis, cancer support services, and rehabilitation. For the patients and families of Seattle Children’s cancer program, the accreditation ensures a multidisciplinary team approach for coordination of the best available treatment options, and care that includes a comprehensive range of state-of-the-art services and equipment.

The CoC, a consortium of professional organizations whose objective is to improve survival and quality of life for cancer patients, was established in 1922 by the American College of Surgeons. Its survey of Children’s took place in November 2010, auditing years 2007-2009, and the accreditation is valid through November 2013.

“Our all-inclusive team of pediatric cancer experts treat 230 children newly diagnosed with cancer every year, and provides follow-up care to more than 3,000 children and adolescents,” said Douglas Hawkins, MD, Associate Hematology/Oncology Division Chief at Seattle Children’s Hospital. “Our CoC accreditation provides further validation of Children’s commitment to provide the best quality care and support to our patients and their families.”

ABRET Accreditation for EEG Laboratories

ABRET - the national credentialing board for EEG technologists and other technologists serving the electroneurodiagnostic community – awarded Children’s their EEG Laboratory Accreditation based on technical excellence of the EEGs performed in the Hospital’s neurodiagnostic EEG laboratory. The accreditation means the laboratory has met strict standards and is to be recognized as a place where patients and physicians can have confidence they are receiving the best in EEG care and diagnostics.

Areas evaluated by ABRET for the accreditation included technical standards, the quality of the laboratory’s output, safety, and lab management issues.

“Our ABRET EEG Laboratory Accreditation is a testament to Children’s relentless effort to be the best pediatric hospital in the country,” said Sidney Gospe, MD, PhD, Neurology Division Chief at Seattle Children’s Hospital. “We are pleased to have been awarded the accreditation, as it underscores Children’s commitment to meeting and exceeding neurodiagnostic industry standards for patient care.”

For More Information:

About Seattle Children’s

Consistently ranked as one of the best children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical referral center for the largest landmass of any children’s hospital in the country (Washington, Alaska, Montana and Idaho). For more than 100 years, Seattle Children’s has been delivering superior patient care while advancing new treatments through pediatric research. Seattle Children’s serves as the primary teaching, clinical and research site for the Department of Pediatrics at the University of Washington School of Medicine. The hospital works in partnership with Seattle Children’s Research Institute and Seattle Children’s Hospital Foundation. For more information, visit or follow us on Twitter or Facebook.